Literature DB >> 15322757

[Interstitial cystitis. Current aspects of diagnosis and therapy].

A Loch1, U Stein.   

Abstract

Interstitial cystitis is a chronic, heterogeneous syndrome that is characterized by the classic symptoms of bladder pain, nycturia, and pollakiuria. Population studies have shown an increase in prevalence and incidence. Different hypotheses exist about the etiology and pathogenesis. Epithelial dysfunction and neuro-urothelial interaction are the most frequently used causal models. Utilization of the official diagnosis criteria of the NIDDK (National Institute of Diabetes, Digestive and Kidney Disease) should be flexible and individual in order not to overlook early forms of IC. Since there is no pathognomonic marker, diagnosis of IC is a combination of typical patient history and exclusion of differential diagnoses. Cystoscopy and biopsies are not specific; however, they can provide useful information on extent and aid in treatment choice. The effectiveness of conservative therapy has been increased by using electromotive drug administration (EMDA) in instillation therapy.

Entities:  

Mesh:

Year:  2004        PMID: 15322757     DOI: 10.1007/s00120-004-0664-9

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  12 in total

Review 1.  Interstitial cystitis in adolescents and children: a review.

Authors:  T F Mattox
Journal:  J Pediatr Adolesc Gynecol       Date:  2004-02       Impact factor: 1.814

2.  The role of urinary potassium in the pathogenesis and diagnosis of interstitial cystitis.

Authors:  C L Parsons; M Greenberger; L Gabal; M Bidair; G Barme
Journal:  J Urol       Date:  1998-06       Impact factor: 7.450

3.  Incidence of physician-diagnosed interstitial cystitis in Olmsted County: a community-based study.

Authors:  R O Roberts; E J Bergstralh; S E Bass; D J Lightner; M M Lieber; S J Jacobsen
Journal:  BJU Int       Date:  2003-02       Impact factor: 5.588

4.  The cysteinyl leukotriene D4 receptor antagonist montelukast for the treatment of interstitial cystitis.

Authors:  K Bouchelouche; J Nordling; T Hald; P Bouchelouche
Journal:  J Urol       Date:  2001-11       Impact factor: 7.450

5.  Comparison of APF activity and epithelial growth factor levels in urine from Chinese, African-American, and white American patients with interstitial cystitis.

Authors:  Chen-O u Zhang; Ze-Liang Li; Joanna L Shoenfelt; Chui-Ze Kong; Toby C Chai; Deborah R Erickson; Kenneth M Peters; Eric S Rovner; Susan Keay
Journal:  Urology       Date:  2003-05       Impact factor: 2.649

Review 6.  Interstitial cystitis: understanding the syndrome.

Authors:  Keri Marshall
Journal:  Altern Med Rev       Date:  2003-11

7.  Prevalence of symptoms related to interstitial cystitis in women: a population based study in Finland.

Authors:  Mikael Leppilahti; Teuvo L J Tammela; Heini Huhtala; Anssi Auvinen
Journal:  J Urol       Date:  2002-07       Impact factor: 7.450

8.  Antiproliferative factor, heparin-binding epidermal growth factor-like growth factor, and epidermal growth factor in men with interstitial cystitis versus chronic pelvic pain syndrome.

Authors:  Susan Keay; Chen-Ou Zhang; Toby Chai; John Warren; Kristopher Koch; David Grkovic; Heidi Colville; Richard Alexander
Journal:  Urology       Date:  2004-01       Impact factor: 2.649

9.  Prevalence of interstitial cystitis in first-degree relatives of patients with interstitial cystitis.

Authors:  John W Warren; Theresa L Jackson; Patricia Langenberg; Deborah J Meyers; Jianfeng Xu
Journal:  Urology       Date:  2004-01       Impact factor: 2.649

10.  Different clinical presentation of interstitial cystitis syndrome.

Authors:  D Porru; R Politanò; M Gerardini; G L Giliberto; S Stancati; L Pasini; C Tinelli; B Rovereto
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2004-02-05
View more
  3 in total

1.  [Inpatient urologic rehabilitation in interstitial cystitis].

Authors:  W Vahlensieck
Journal:  Urologe A       Date:  2005-01       Impact factor: 0.639

2.  [Intravesical therapy for overactive bladder].

Authors:  J Pannek; U Grigoleit; R Wormland; M Goepel
Journal:  Urologe A       Date:  2006-02       Impact factor: 0.639

Review 3.  [Diagnosis and treatment of interstitial cystitis (IC/PBS) : S2k guideline of the German Society of Urology].

Authors:  T Bschleipfer; R Doggweiler; D Schultz-Lampel; J de Jong; A Gonsior; J Hensen; E Heßdörfer; B T Kaftan; A Kuhn; U Kunzendorf; A Lampel; A Landmesser; A Loch; O Moormann; B Müller; J Neuhaus; A Reich; R Roth; S Schumacher; R Stratmeyer; W Vahlensieck; A Wördehoff; B Münder-Hensen
Journal:  Urologe A       Date:  2019-11       Impact factor: 0.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.